Home > News > Smaller Probes, Earlier Detection
February 22nd, 2010
Smaller Probes, Earlier Detection
Abstract:
Shad Thaxton, PhD: Growing up, I used to watch the G.I. Joe cartoon series. At the end of every episode was a short announcement by a G.I. Joe hero on any number of topics, ranging from avoiding old refrigerators as hiding places to promoting sportsmanship on the athletic field. Each would end with one of the characters saying, "Now we know!" followed by the G.I. Joe hero with "And knowing is half the battle."
We throw that phrase around occasionally in my laboratory, where we develop improved diagnostics for diseases like prostate cancer. Determining the disease at hand as early as possible is crucial to positive outcomes for patients. Of course, the other half of the battle is having an effective treatment. Although this piece focuses on the first part of the battle, we are working on the treatment part too.
Collaborative work with my laboratory; Chad Mirkin, professor of chemistry at Northwestern; Dr. William Catalona, a prostate cancer surgeon and expert at Northwestern; and biotech company Nanosphere uses recent advances in nanotechnology to improve upon the current PSA test and answer some of these questions. But, before we explore how the new test works, let's first take a look at how PSA is measured in the current process.
Source:
northwestern.edu
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||